Cancer Clinical Trials

Explore Open Trials

227

Recruiting

Pediatric

Accept Healthy

Stanford Cancer Institute offers leading edge research and compassionate care with over 250 actively recruiting clinical trials, investigating a broad spectrum of new diagnostic, prevention and treatment strategies.

Research Programs

Explore research programs powered by innovation, compassion, and discovery

Cancer Biology and Cancer Stem Cells

Investigating the molecules, mechanisms and pathways involved in cancer pathogenesis.
Cancer Imaging and Early Detection

Advancing cancer research, early detection, management and outcomes through multiple novel anatomical and molecular imaging strategies.
Cancer Immunotherapy

Linking SCI's basic science and clinical translational strengths to provide further opportunities for synergy and collaboration.

Explore all Research Programs

Events

See how we foster collaboration and showcase cutting edge research

Advances in Mass Spectrometry Enabled Drug Discovery

October 29, 2024
Tuesday
8:20 AM to 5:35 PM

Stanford Cancer Institute

475 Via Ortega
Stanford, California 94305
Mackenzie Room, Jen-Hsun Huang Engineering Center

REGISTER
Breakthroughs in Cancer: Cornelia Ulrich, PhD, MS

November 12, 2024
Tuesday
4:00 PM to 5:00 PM

Stanford Cancer Institute

279 Campus Drive West
Stanford, California 94305
Munzer Auditorium, Beckman CenterVirtual Event

REGISTER
Perspectives on Progress in Cancer: A Tribute to Dr. Beverly Mitchell

November 21, 2024
Thursday
1:00 PM to 7:00 PM

Stanford Cancer Institute

326 Galvez St.
Stanford, California 94305
Frances C. Arrillage Alumni Center

REGISTER

More Stanford Cancer Events

News

Discover how the Institute is translating Stanford discoveries into individualized cancer care

October 8, 2024
| Stanford Cancer Institute

The intersection of cancer and disability

While some people with cancer have pre-existing disabilities, most patients are newly disabled as a result of their cancer diagnosis and encounter unique challenges related to their treatments.
September 24, 2024
| Stanford Cancer Institute

Navigating the risks of childhood cancer predispositions

Ten percent of childhood cancers are associated with a cancer predisposition syndrome caused by mutations to genes that prevent tumor growth or that drive cell growth and division.
September 20, 2024
| Stanford Cancer Institute

Stanford CAR-T solid tumor study enrolls first pediatric patient

In September 2024, the first patient received treatment in the phase 1 clinical trial evaluating engineered immune cells for pediatric solid tumors.